Pediatric Acute Myocarditis With Short-Term Outcomes and Factors for Extracorporeal Membrane Oxygenation: A

Ta Anh Tuan1,2,3, Tran Dang Xoay1, Phan Huu Phuc1

  • 1Pediatric Intensive Care Unit, Vietnam National Children's Hospital, Hanoi, Vietnam.

Insights

This study found a 30% mortality rate in children with acute myocarditis, with 32% of those requiring extracorporeal membrane oxygenation (ECMO) not surviving. Low ejection fraction and high lactate levels post-ECMO indicated poor outcomes.

Area of Science:

  • Pediatric Cardiology
  • Critical Care Medicine
  • Extracorporeal Life Support

Background:

  • Limited data exists on acute myocarditis management and outcomes using extracorporeal membrane oxygenation (ECMO) in low- and middle-income countries.
  • Acute myocarditis in children can lead to severe hemodynamic compromise requiring advanced support.
  • Understanding outcomes and predictors of ECMO use is crucial for improving pediatric critical care in resource-limited settings.

Purpose of the Study:

  • To determine the short-term outcomes of pediatric acute myocarditis patients treated with ECMO.
  • To identify factors associated with ECMO use and outcomes in children with acute myocarditis.
  • To provide insights into ECMO management for acute myocarditis in a tertiary Vietnamese hospital.

Main Methods:

  • A retrospective observational study was conducted from January 2016 to February 2021.
  • Included were pediatric patients aged 1 month to 16 years diagnosed with acute myocarditis.
  • Data analysis focused on short-term outcomes, ECMO utilization, and associated clinical and laboratory variables.

Main Results:

  • A total of 54 pediatric patients with acute myocarditis were analyzed; 37 received ECMO support.
  • The overall case fatality rate was 30% (16/54), with 32% (12/37) mortality among ECMO patients.
  • Factors associated with non-survival included lower left ventricular ejection fraction (LVEF) at 48 hours, lower platelet count, lower protein levels, and higher vasoactive-inotropic score and lactate levels post-ECMO.

Conclusions:

  • Acute myocarditis carries a significant mortality risk, particularly for children requiring ECMO support.
  • Low LVEF, elevated lactate, and high vasoactive-inotropic scores post-ECMO are indicators of poor prognosis.
  • Arrhythmia in the context of cardiogenic shock was identified as an indicator for ECMO initiation.

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
422
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
30
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
377
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
232
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
386
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
266